Table of Content

1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Group ACYW135 Meningococcal Polysaccharide Vaccine
1.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Class I Vaccines
1.2.3 Class II Vaccines
1.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue 2024-2034
1.4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales 2024-2034
1.4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2024-2024)
2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price by Manufacturers (2024-2024)
2.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine, Product Type & Application
2.7 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.7.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Group ACYW135 Meningococcal Polysaccharide Vaccine Players Market Share by Revenue
2.7.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Group ACYW135 Meningococcal Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region: 2024-2034
3.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region: 2024-2024
3.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region: 2024-2034
3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region: 2024-2034
3.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region: 2024-2024
3.3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region: 2024-2034
3.4 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034)
3.4.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.5.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034)
3.5.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034)
3.6.3 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034)
3.7.3 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034)
3.8.3 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2024-2034)
4.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2024-2024)
4.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2024-2034)
4.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2024-2034)
4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2024-2034)
4.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2024-2024)
4.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2024-2034)
4.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2024-2034)
4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2024-2034)
5 Segment by Application
5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2024-2034)
5.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2024-2024)
5.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2024-2034)
5.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2024-2034)
5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2024-2034)
5.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2024-2024)
5.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2024-2034)
5.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2024-2034)
5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Sanofi-Pasteur
6.1.1 Sanofi-Pasteur Corporation Information
6.1.2 Sanofi-Pasteur Description and Business Overview
6.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.1.5 Sanofi-Pasteur Recent Developments/Updates
6.2 Walvax Biotechnology
6.2.1 Walvax Biotechnology Corporation Information
6.2.2 Walvax Biotechnology Description and Business Overview
6.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.2.5 Walvax Biotechnology Recent Developments/Updates
6.3 Chengdu Kanghua Biological Products Co., Ltd
6.3.1 Chengdu Kanghua Biological Products Co., Ltd Corporation Information
6.3.2 Chengdu Kanghua Biological Products Co., Ltd Description and Business Overview
6.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
6.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
6.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
6.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Description and Business Overview
6.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
6.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
6.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Corporation Information
6.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Description and Business Overview
6.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
6.6 Beijing Institute of Biological Products Co., Ltd
6.6.1 Beijing Institute of Biological Products Co., Ltd Corporation Information
6.6.2 Beijing Institute of Biological Products Co., Ltd Description and Business Overview
6.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
6.7 CanSino Biologics AG
6.6.1 CanSino Biologics AG Corporation Information
6.6.2 CanSino Biologics AG Description and Business Overview
6.6.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.4.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.7.5 CanSino Biologics AG Recent Developments/Updates
6.8 Yuxi Watson Biotechnology Co., Ltd
6.8.1 Yuxi Watson Biotechnology Co., Ltd Corporation Information
6.8.2 Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
6.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
6.9 Hualan Biovaccine Co., Ltd
6.9.1 Hualan Biovaccine Co., Ltd Corporation Information
6.9.2 Hualan Biovaccine Co., Ltd Description and Business Overview
6.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.9.5 Hualan Biovaccine Co., Ltd Recent Developments/Updates
6.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
6.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Corporation Information
6.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Description and Business Overview
6.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Portfolio
6.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Chain Analysis
7.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Mode & Process
7.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales and Marketing
7.4.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Channels
7.4.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors
7.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Customers
8 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Dynamics
8.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends
8.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
8.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Challenges
8.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Group ACYW135 Meningococcal Polysaccharide Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Group ACYW135 Meningococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Group ACYW135 Meningococcal Polysaccharide Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2024-2024) & (K Units)
Table 18. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2024-2024)
Table 19. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2024-2034) & (K Units)
Table 20. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2024-2034)
Table 21. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2024-2024)
Table 23. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2024-2034)
Table 25. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2024) & (K Units)
Table 27. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034) & (K Units)
Table 28. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2024) & (K Units)
Table 32. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) by Type (2024-2024)
Table 51. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) by Type (2024-2034)
Table 52. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2024-2024)
Table 53. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2024-2034)
Table 54. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2024-2024)
Table 57. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2024-2034)
Table 58. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price (US$/Unit) by Type (2024-2024)
Table 59. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price (US$/Unit) by Type (2024-2034)
Table 60. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) by Application (2024-2024)
Table 61. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units) by Application (2024-2034)
Table 62. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2024-2024)
Table 63. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2024-2034)
Table 64. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2024-2024)
Table 67. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2024-2034)
Table 68. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price (US$/Unit) by Application (2024-2024)
Table 69. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price (US$/Unit) by Application (2024-2034)
Table 70. Sanofi-Pasteur Corporation Information
Table 71. Sanofi-Pasteur Description and Business Overview
Table 72. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 74. Sanofi-Pasteur Recent Developments/Updates
Table 75. Walvax Biotechnology Corporation Information
Table 76. Walvax Biotechnology Description and Business Overview
Table 77. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 79. Walvax Biotechnology Recent Developments/Updates
Table 80. Chengdu Kanghua Biological Products Co., Ltd Corporation Information
Table 81. Chengdu Kanghua Biological Products Co., Ltd Description and Business Overview
Table 82. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 84. Chengdu Kanghua Biological Products Co., Ltd Recent Developments/Updates
Table 85. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
Table 86. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Description and Business Overview
Table 87. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 89. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 90. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Corporation Information
Table 91. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Description and Business Overview
Table 92. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 94. Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 95. Beijing Institute of Biological Products Co., Ltd Corporation Information
Table 96. Beijing Institute of Biological Products Co., Ltd Description and Business Overview
Table 97. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 99. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 100. CanSino Biologics AG Corporation Information
Table 101. CanSino Biologics AG Description and Business Overview
Table 102. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 104. CanSino Biologics AG Recent Developments/Updates
Table 105. Yuxi Watson Biotechnology Co., Ltd Corporation Information
Table 106. Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
Table 107. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 109. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 110. Hualan Biovaccine Co., Ltd Corporation Information
Table 111. Hualan Biovaccine Co., Ltd Description and Business Overview
Table 112. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 114. Hualan Biovaccine Co., Ltd Recent Developments/Updates
Table 115. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Corporation Information
Table 116. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Description and Business Overview
Table 117. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product
Table 119. Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors List
Table 123. Group ACYW135 Meningococcal Polysaccharide Vaccine Customers List
Table 124. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Trends
Table 125. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
Table 126. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Challenges
Table 127. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 2. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Type in 2022 & 2034
Figure 4. Class I Vaccines Product Picture
Figure 5. Class II Vaccines Product Picture
Figure 6. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 11. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size (2024-2034) & (US$ Million)
Figure 12. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales (2024-2034) & (K Units)
Figure 13. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Average Price (US$/Unit) & (2024-2034)
Figure 14. Group ACYW135 Meningococcal Polysaccharide Vaccine Report Years Considered
Figure 15. Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Group ACYW135 Meningococcal Polysaccharide Vaccine Players: Market Share by Revenue in 2022
Figure 18. Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 19. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 20. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2024-2034)
Figure 21. North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2024-2034)
Figure 22. United States Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 23. Canada Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 24. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2024-2034)
Figure 25. Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2024-2034)
Figure 26. Germany Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. France Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. U.K. Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Italy Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. Russia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Region (2024-2034)
Figure 32. Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Region (2024-2034)
Figure 33. China Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Japan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. South Korea Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. India Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. Australia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. China Taiwan Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Southeast Asia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2024-2034)
Figure 41. Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2024-2034)
Figure 42. Mexico Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Brazil Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Argentina Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Country (2024-2034)
Figure 46. Middle East & Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Country (2024-2034)
Figure 47. Turkey Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. UAE Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Global Sales Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine by Type (2024-2034)
Figure 51. Global Revenue Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine by Type (2024-2034)
Figure 52. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price (US$/Unit) by Type (2024-2034)
Figure 53. Global Sales Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine by Application (2024-2034)
Figure 54. Global Revenue Market Share of Group ACYW135 Meningococcal Polysaccharide Vaccine by Application (2024-2034)
Figure 55. Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price (US$/Unit) by Application (2024-2034)
Figure 56. Group ACYW135 Meningococcal Polysaccharide Vaccine Value Chain
Figure 57. Group ACYW135 Meningococcal Polysaccharide Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed